Carlson Capital’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-43,986
Closed -$12.4M 249
2019
Q2
$12.4M Sell
43,986
-11,211
-20% -$3.06M 0.19% 155
2019
Q1
$15.8M Buy
55,197
+43,475
+371% +$12.6M 0.28% 122
2018
Q4
$3.08M Sell
11,722
-32,693
-74% -$8.99M 0.05% 234
2018
Q3
$12.2M Buy
+44,415
New +$11.5M 0.15% 163
2017
Q1
Sell
-86,643
Closed -$12.5M 274
2016
Q4
$12.5M Buy
+86,643
New +$11.6M 0.15% 167
2015
Q4
Sell
-112,100
Closed -$15.7M 327
2015
Q3
$15.7M Buy
+112,100
New +$16.8M 0.18% 162
2014
Q4
Sell
-191,045
Closed -$22.9M 341
2014
Q3
$22.9M Sell
191,045
-193,645
-50% -$22.2M 0.25% 139
2014
Q2
$41.4M Sell
384,690
-230,675
-37% -$23.8M 0.45% 75
2014
Q1
$61.3M Sell
615,365
-1,472,813
-71% -$133M 0.71% 38
2013
Q4
$193M Buy
2,088,178
+418,578
+25% +$37.2M 2.19% 2
2013
Q3
$140M Sell
1,669,600
-389,000
-19% -$33.3M 1.88% 2
2013
Q2
$168M Buy
+2,058,600
New +$154M 2.02% 4

Other funds holding ELV

Carlson Capital's ELV Position: Q3 2019 in Review

Carlson Capital sold out of Elevance Health (ELV) in Q3 2019, closing a stake of 43,986 shares — an estimated $12.4M sold.

Carlson Capital first reported a position in ELV in Q2 2013 and held it in 12 quarters. The position peaked at $193M in Q4 2013. 1,016 funds tracked by Wall St. Rank hold ELV as of Q3 2019.

  • Carlson Capital reported no remaining Elevance Health position as of Q3 2019 after selling out during the quarter.
  • Carlson Capital sold 43,986 Elevance Health shares in Q3 2019, an estimated $12.4M.
  • Carlson Capital first reported a position in Elevance Health in Q2 2013 and held it in 12 quarters.
  • Carlson Capital's Elevance Health position peaked at $193M in Q4 2013.
  • 1,016 funds tracked by Wall St. Rank held Elevance Health as of Q3 2019.

Based on Carlson Capital's 13F filing for Q3 2019, filed 13 Nov 2019.